Patents by Inventor Michael Forte

Michael Forte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MICROPOROUS STRUCTURED SORBENTS
    Publication number: 20260042081
    Abstract: Structured sorbents including a metal organic framework, hydrophobic binder, and hydrophobic carrier, wherein the hydrophobic carrier includes fluorinated silica. Methods of making structured sorbents and using structured sorbents in direct air capture of CO2.
    Type: Application
    Filed: August 8, 2024
    Publication date: February 12, 2026
    Inventors: Junyan Yang, Brian Hanna, Wajdi Al-Sadat, Michael Forte, Douglas Theberge, Mourad Younes, Ammar Al-Ahmed, Dana A. Wong
  • Second generation inhibitors of mitochondrial permeability transition pore with improved plasma stability
    Patent number: 12398110
    Abstract: The present invention provides compounds useful as mitochondrial permeability transition pore (mtPTP) inhibitors, the compounds being of Formula (I), or a pharmaceutically acceptable salt thereof wherein R1 is selected from the group of H, halogen, and C1-C3 alkyl; and R2 is selected from the group of H, CF3, and halogen; with the proviso that at least one of R1 and R2 is halogen or CF3.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: August 26, 2025
    Assignee: Oregon Health & Science University
    Inventors: Michael Cohen, Michael Forte, Justina Sileikyte, Aaron Nilsen, Jordan Devereaux, Paolo Bernardi
  • SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)
    Publication number: 20240067600
    Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
    Type: Application
    Filed: March 16, 2023
    Publication date: February 29, 2024
    Applicants: UNIVERSITY OF KANSAS, Oregon Health & Science University
    Inventors: Sudeshna ROY, Paolo BERNARDI, Michael FORTE, Frank SCHOENEN, Justina SILEIKYTE
  • SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)
    Publication number: 20220396547
    Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
    Type: Application
    Filed: December 14, 2020
    Publication date: December 15, 2022
    Inventors: Sudeshna ROY, Paolo BERNARDI, Michael FORTE, Frank SCHOENEN, Justina SILEIKYTE
  • SECOND GENERATION INHIBITORS OF MITOCHONDRIAL PERMEABILITY TRANSITION PORE WITH IMPROVED PLASMA STABILITY
    Publication number: 20220289690
    Abstract: The present invention provides compounds useful as mitochondrial permeability transition pore (mtPTP) inhibitors, the compounds being of Formula (I), or a pharmaceutically acceptable salt thereof wherein R1 is selected from the group of H, halogen, and C1-C3 alkyl; and R2 is selected from the group of H, CF3, and halogen; with the proviso that at least one of R1 and R2 is halogen or CF3.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 15, 2022
    Applicant: Oregon Health & Science University
    Inventors: Michael Cohen, Michael Forte, Justina Sileikyte, Aaron Nilsen, Jordan Devereaux, Paolo Bernardi
  • Small molecule inhibitors of the mitochondrial permeability transition pore (mtPTP)
    Patent number: 10865181
    Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
    Type: Grant
    Filed: November 4, 2015
    Date of Patent: December 15, 2020
    Assignees: UNIVERSITY OF KANSAS, Oregon Health & Science University
    Inventors: Sudeshna Roy, Paolo Bernardi, Michael Forte, Frank Schoenen, Justina Sileikyte
  • SMALL MOLECULE INHIBITORS OF THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE (mtPTP)
    Publication number: 20180282264
    Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
    Type: Application
    Filed: November 4, 2015
    Publication date: October 4, 2018
    Inventors: Sudeshna ROY, Paolo BERNARDI, Michael FORTE, Frank SCHOENEN, Justina SILEIKYTE
  • Cyclic undecapeptides and derivatives as multiple sclerosis therapies
    Patent number: 8394763
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of a cyclosporin compound.
    Type: Grant
    Filed: September 26, 2008
    Date of Patent: March 12, 2013
    Assignees: Oregon Health & Science University, The United States of America as represented by the Department of Veterans Affairs
    Inventors: Michael Forte, Dennis Bourdette, Gail Marracci
  • Passenger Extraction Program and a Method of Extraction
    Publication number: 20120246082
    Abstract: The extraction program and method of extraction of the present invention can be utilized by emergency response personnel to safely extract passengers from a vehicle and handle hazardous chemical spills. Another embodiment of the present invention provides for vehicle make and model recognition technology. Another embodiment provides for damage estimates to be given in a speedy manner.
    Type: Application
    Filed: March 17, 2012
    Publication date: September 27, 2012
    Inventors: Michael Forte, Adam Weiss
  • CYCLIC UNDECAPEPTIDES AND DERIVATIVES AS MULTIPLE SCLEROSIS THERAPIES
    Publication number: 20100196317
    Abstract: A method for treating a subject with multiple sclerosis is disclosed herein. In one embodiment, a method is provided for treating a subject with multiple sclerosis that includes administering to the subject a therapeutically effective amount of a cyclosporin compound.
    Type: Application
    Filed: September 26, 2008
    Publication date: August 5, 2010
    Inventors: Michael Forte, Dennis Bourdette, Gail Marracci